JOHN COLTON: Open Payments
NPI 1043640956 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,536 in 155 payments from 19 companies in 2025. Trend: 2023 $390 · 2024 $1,029 · 2025 $2,536
Food & beverage: $2,505Education: $31
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $605 |
| GENZYME CORPORATION | 9 | $280 |
| Janssen Biotech, Inc. | 25 | $236 |
| Ardelyx, Inc. | 9 | $181 |
| Aimmune Therapeutics, Inc. | 19 | $176 |
| Madrigal Pharmaceuticals | 7 | $149 |
| QOL Medical, LLC | 5 | $148 |
| Regeneron Healthcare Solutions, Inc. | 5 | $131 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $116 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $109 |
Products named: DUPIXENT, TREMFYA, IBSRELA, CREON, RINVOQ, REZDIFFRA, Sucraid, ZENPEP.
Industry payments across SC — which companies pay providers there.
